With regard to dietary supplements , patients should be aware of the following: Herbal supplements with hypoglycaemic properties such as berberine, bitter melon, or fenugreek may enhance blood glucose-lowering effects and increase hypoglycaemia risk, particularly when used alongside insulin or sulfonylureas
UpToDate, Last updated: 2026
"I am on the lowest dose of the Wegovy pill
The analysed approaches were either equal in terms of calorie supply or allowed ad libitum consumption
International Regulatory Landscape Healthcare Provider Considerations Healthcare providers who prescribe or recommend BPC-157 face potential: Disciplinary action from state medical boards Medical license implications (sanctions, restrictions, suspension) Malpractice liability (insurance often excludes experimental treatments) Federal regulatory enforcement Research and Access Legitimate research pathways: Investigational New Drug (IND) application required for human research Institutional Review Board (IRB) approval required GMP standards required for research-grade materials Current access: Research peptide suppliers (variable quality) Some compounding pharmacies (legal status varies) Clinical trials (limited availability) Why This Regulatory Status Exists BPC-157's prohibition stems from: Limited clinical data Only small pilot studies published (~28 human subjects total)

The SLEP findings about conventional drugs do not apply to peptide therapeutics, and anyone telling you otherwise is dangerously oversimplifying the science